Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.93 USD | -3.73% |
|
-9.05% | -0.45% |
Jan. 14 | Nuvalent, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 09:00 AM | |
Jan. 08 | Nuvalent Insider Sold Shares Worth $320,009, According to a Recent SEC Filing | MT |
Capitalization | 5.54B 5.27B 4.97B 4.39B 7.85B 480B 8.71B 59.2B 21.93B 201B 20.76B 20.34B 842B | P/E ratio 2024 * |
-19.8x | P/E ratio 2025 * | -17.2x |
---|---|---|---|---|---|
Enterprise value | 4.55B 4.33B 4.09B 3.61B 6.45B 394B 7.16B 48.68B 18.03B 165B 17.07B 16.72B 692B | EV / Sales 2024 * |
-
| EV / Sales 2025 * | 705x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Nuvalent, Inc.
1 day | -3.73% | ||
1 week | -9.05% | ||
Current month | -9.18% | ||
1 month | +0.63% | ||
3 months | -10.30% | ||
6 months | +8.37% | ||
Current year | -0.45% |







Director | Title | Age | Since |
---|---|---|---|
James Porter
CEO | Chief Executive Officer | 49 | 2016-12-31 |
Alexandra Balcom
DFI | Director of Finance/CFO | 41 | 2020-12-31 |
Henry Pelish
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-10 |
Manager | Title | Age | Since |
---|---|---|---|
James Porter
BRD | Director/Board Member | 49 | 2020-01-31 |
Matthew Shair
BRD | Director/Board Member | 56 | 2016-12-31 |
Cameron Wheeler
CHM | Chairman | 46 | 2017-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | +3.64% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-3.73% | -9.05% | -7.78% | +325.38% | 5.54B | ||
-0.77% | -2.20% | +7.67% | +96.65% | 118B | ||
-0.10% | -5.13% | -29.45% | +6.90% | 72.09B | ||
-2.13% | -3.83% | +68.23% | +140.90% | 38.79B | ||
-2.40% | +1.89% | +28.97% | -26.68% | 28.73B | ||
+2.38% | +3.29% | +58.05% | +4.99% | 24.63B | ||
+4.61% | +2.25% | +11.97% | -36.61% | 23.61B | ||
-2.06% | +6.27% | +357.60% | +957.92% | 15.76B | ||
+0.81% | -0.80% | +175.86% | +226.51% | 14.19B | ||
+0.94% | +8.59% | -19.89% | -31.61% | 13.46B | ||
Average | -0.24% | +0.05% | +65.12% | +166.44% | 35.47B | |
Weighted average by Cap. | -0.31% | -1.28% | +33.25% | +100.19% |
2024 * | 2025 * | |
---|---|---|
Net sales | - | 6.82M 6.49M 6.12M 5.41M 9.66M 591M 10.72M 72.89M 27.01M 247M 25.56M 25.04M 1.04B |
Net income | -258M -245M -231M -204M -365M -22.32B -405M -2.75B -1.02B -9.33B -966M -946M -39.18B | -312M -297M -280M -248M -442M -27.05B -491M -3.34B -1.24B -11.31B -1.17B -1.15B -47.49B |
Net Debt | -984M -937M -884M -780M -1.39B -85.25B -1.55B -10.52B -3.9B -35.65B -3.69B -3.61B -150B | -729M -694M -654M -578M -1.03B -63.14B -1.15B -7.79B -2.89B -26.4B -2.73B -2.68B -111B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-14 | 77.93 $ | -3.73% | 525,693 |
25-02-13 | 80.95 $ | -0.36% | 310,151 |
25-02-12 | 81.24 $ | -2.00% | 366,197 |
25-02-11 | 82.90 $ | -0.53% | 323,571 |
25-02-10 | 83.34 $ | -2.73% | 221,526 |
Delayed Quote Nasdaq, February 14, 2025 at 04:00 pm EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NUVL Stock